TPX-0022, a polypharmacology inhibitor of MET/CSF1R/SRC for treatment of cancers with abnormal HGF/MET signalingDayong Zhai,Evan Rogers,Wei Deng, Xin Zhang,Dong Lee,Jane Ung,Han Zhang,Jing Liu, Yuelie Lu,John Huang,Armin Graber,Zach Zimmerman,John Lim,Jeffrey Whitten,J. Jean CuiCANCER RESEARCH(2019)引用 3|浏览28暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要